In Vivo Repair of a Protein Underlying a Neurological Disorder by Programmable RNA Editing

John R. Sinnamon, Susan Y. Kim, Jenna R. Fisk, Zhen Song, Hiroyuki Nakai, Sophia Jeng, Shannon K. McWeeney, Gail Mandel

Research output: Contribution to journalArticle

Abstract

Programmable RNA editing is gaining momentum as an approach to repair mutations, but its efficiency in repairing endogenous mutant RNA in complex tissue is unknown. Here we apply this approach to the brain and successfully repair a guanosine-to-adenosine mutation in methyl CpG binding protein 2 RNA that causes the neurodevelopmental disease Rett syndrome. Repair is mediated by hippocampal injections of juvenile Mecp2317G>A mice with an adeno-associated virus expressing the hyperactive catalytic domain of adenosine deaminase acting on RNA 2 and Mecp2 guide. After 1 month, 50% of Mecp2 RNA is recoded in three different hippocampal neuronal populations. MeCP2 protein localization to heterochromatin is restored in neurons to 50% of wild-type levels. Whole-transcriptome RNA analysis of one neuronal population indicates that the majority of off-target editing sites exhibit rates of 30% or less. This study demonstrates that programmable RNA editing can be utilized to repair mutations in mouse models of neurological disease.

Original languageEnglish (US)
Article number107878
JournalCell Reports
Volume32
Issue number2
DOIs
StatePublished - Jul 14 2020

Keywords

  • ADAR
  • MeCP2
  • RNA editing
  • Rett syndrome
  • adenosine deaminase acting on RNA

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'In Vivo Repair of a Protein Underlying a Neurological Disorder by Programmable RNA Editing'. Together they form a unique fingerprint.

  • Cite this